GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y 1 receptor antagonists and neuropeptide Y Y 4 receptor agonists

Author： Parker E.M.   Babij C.K.   Balasubramaniam A.   Burrier R.E.   Guzzi M.   Hamud F.   Gitali Mukhopadhyay   Rudinski M.S.   Tao Z.   Tice M.   Xia L.   Mullins D.E.   Salisbury B.G.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.349, Iss.1, 1998-05, pp. : 97-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropeptide Y receptor antagonists

By Ling A.L.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 4, 1999-04 ,pp. : 375-384

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptide Y receptor antagonists in obesity

By Gehlert D.R.   Hipskind P.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1827-1838

Informa Healthcare

Access to resources Recommend Favorite

GW1229, a novel neuropeptide Y Y 1 receptor antagonist, inhibits the vasoconstrictor effect of neuropeptide Y in the hamster microcirculation

By Bitran M.   Daniels A.J.   Boric M.P.  

European Journal of Pharmacology, Vol. 319, Iss. 1, 1997-01 ,pp. : 43-47

Elsevier

Access to resources Recommend Favorite

Recent developments with neuropeptide Y receptor antagonists

By Lundberg J.M.   Modin A.   Malmstrom R.E.  

Trends in Pharmacological Sciences, Vol. 17, Iss. 9, 1996-09 ,pp. : 301-304

Elsevier

Access to resources Recommend Favorite

Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y 1 receptor

By Bergdahl A.   Nilsson T.   Cantera L.   Nilsson L.   Xiang-Ying S.   Hedner T.   Erlinge D.   Valdemarson S.   Edvinsson L.  

European Journal of Pharmacology, Vol. 316, Iss. 1, 1996-11 ,pp. : 59-64

Elsevier

Access to resources Recommend Favorite